Aya El Helali

516 total citations
34 papers, 288 citations indexed

About

Aya El Helali is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aya El Helali has authored 34 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aya El Helali's work include Glioma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Aya El Helali is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Aya El Helali collaborates with scholars based in Hong Kong, China and United Kingdom. Aya El Helali's co-authors include Chi‐Leung Chiang, Richard D. Kennedy, Tai‐Chung Lam, Wing Chiu Dai, Kwan Man, Wenqi Chen, Albert Chan, Natalie Wong, Feng Kong and Chung Mau Lo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Aya El Helali

27 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aya El Helali Hong Kong 9 108 94 69 59 53 34 288
Dezuo Dong China 9 122 1.1× 119 1.3× 60 0.9× 77 1.3× 56 1.1× 20 283
Jiashuo Chao China 9 116 1.1× 74 0.8× 67 1.0× 45 0.8× 41 0.8× 20 255
Kang Wang China 11 118 1.1× 109 1.2× 38 0.6× 128 2.2× 78 1.5× 40 366
Qinghua Zhou China 9 144 1.3× 66 0.7× 26 0.4× 73 1.2× 59 1.1× 15 280
Bing Quan China 9 98 0.9× 79 0.8× 158 2.3× 44 0.7× 74 1.4× 24 300
Carminia M. Della Corte Italy 7 139 1.3× 129 1.4× 22 0.3× 103 1.7× 71 1.3× 14 323
Helena Degroote Belgium 11 66 0.6× 86 0.9× 91 1.3× 80 1.4× 30 0.6× 30 309
Ningyuan Wen China 7 62 0.6× 71 0.8× 110 1.6× 63 1.1× 66 1.2× 22 241
Maria Aurelia Barbera Italy 9 134 1.2× 69 0.7× 104 1.5× 70 1.2× 53 1.0× 19 284
Jun Xue China 9 65 0.6× 150 1.6× 41 0.6× 32 0.5× 89 1.7× 26 268

Countries citing papers authored by Aya El Helali

Since Specialization
Citations

This map shows the geographic impact of Aya El Helali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya El Helali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya El Helali more than expected).

Fields of papers citing papers by Aya El Helali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya El Helali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya El Helali. The network helps show where Aya El Helali may publish in the future.

Co-authorship network of co-authors of Aya El Helali

This figure shows the co-authorship network connecting the top 25 collaborators of Aya El Helali. A scholar is included among the top collaborators of Aya El Helali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya El Helali. Aya El Helali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Jason W.H., David Shih, Isaac Ho, et al.. (2025). The diagnostic accuracy of next-generation sequencing in advanced NSCLC. PubMed. 9. 100325–100325.
2.
Chan, Wing‐Lok, Huiqing Hou, Cheuk‐Wai Choi, et al.. (2025). Development and validation of ACTTOP: a prediction model for severe anticancer treatment toxicities in older patients with solid malignancy. Age and Ageing. 54(11). 1 indexed citations
3.
Leung, Gkk, et al.. (2024). The TAC-GReD trial: The combination of talazoparib and carboplatin in DNA damage repair deficient recurrent high-grade glioma.. Journal of Clinical Oncology. 42(16_suppl). 2047–2047.
4.
Kang, Wei, Vincent Ka Chun Yan, Daoud Al‐Badriyeh, et al.. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis. Journal of Pharmaceutical Policy and Practice. 17(1). 2375269–2375269.
5.
Sacher, Adrian G., Miguel A. Villalona‐Calero, Bert H. O’Neil, et al.. (2024). 604O Phase I dose escalation and initial dose expansion results of AMG 193: A MTA-cooperative PRMT5 inhibitor, in patients (pts) with MTAP-deleted solid tumors. Annals of Oncology. 35. S484–S485. 4 indexed citations
6.
Kang, Wei, Vincent Ka Chun Yan, Yue Wei, et al.. (2024). Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis. Nature Communications. 15(1). 5657–5657. 3 indexed citations
7.
Chen, Fang, Qin Liu, Yuanyuan Shen, et al.. (2024). Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancer. Radiotherapy and Oncology. 197. 110333–110333. 1 indexed citations
8.
Tao, Jun, Jianchao Quan, Aya El Helali, Wwt Lam, & Herbert Pang. (2023). Global trends indicate increasing consumption of dietary sodium and fiber in middle-income countries: A study of 30-year global macrotrends. Nutrition Research. 118. 63–69. 5 indexed citations
9.
Helali, Aya El, David Shih, Charlene H. L. Wong, et al.. (2023). The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours. The Lancet Regional Health - Western Pacific. 36. 100775–100775. 6 indexed citations
10.
Chiang, Chi‐Leung, Tai‐Chung Lam, Aya El Helali, et al.. (2023). Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial. The Lancet Regional Health - Western Pacific. 40. 100898–100898. 7 indexed citations
11.
Wang, Ting, Chunxiao Li, Nan Peng, et al.. (2023). MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming. Advanced Science. 10(25). e2300756–e2300756. 27 indexed citations
12.
Helali, Aya El, et al.. (2023). Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019. Cancer Medicine. 12(24). 22316–22324. 3 indexed citations
13.
14.
Hung, Y.S., et al.. (2022). Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study. Cancer Medicine. 12(2). 1997–2007. 10 indexed citations
15.
Helali, Aya El, Charlene H. L. Wong, Cheuk‐Wai Choi, et al.. (2022). A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer. Scientific Reports. 12(1). 3803–3803. 9 indexed citations
16.
Yu, Hao, Fang Chen, Ka-On Lam, et al.. (2022). Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach. Frontiers in Immunology. 13. 768811–768811. 20 indexed citations
17.
18.
Helali, Aya El, et al.. (2021). Adjuvant and post-surgical treatment in non-epithelial ovarian cancer. Best Practice & Research Clinical Obstetrics & Gynaecology. 78. 74–85. 8 indexed citations
19.
Helali, Aya El, Ruth Plummer, Gordon C. Jayson, et al.. (2017). A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours. Annals of Oncology. 28. v128–v128. 5 indexed citations
20.
Korpanty, Grzegorz, et al.. (2012). Bronchoesophageal Fistula in a Patient With Stage IIIB Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 7(10). 1622–1622. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dezuo Dong Breakdown of academic impact, for papers by Jiashuo Chao Breakdown of academic impact, for papers by Kang Wang Breakdown of academic impact, for papers by Qinghua Zhou Breakdown of academic impact, for papers by Bing Quan Breakdown of academic impact, for papers by Carminia M. Della Corte Breakdown of academic impact, for papers by Helena Degroote Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Maria Aurelia Barbera Breakdown of academic impact, for papers by Jun Xue
Rankless by CCL
2026